About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
Meet Our TeamCommitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Videos ›
Webinars ›
Podcasts ›
Scientific Articles ›
Brochures ›
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsJanuary 25, 2023
The Added Value of Biostatistics-Driven Randomization and Trial Supply Management System (RTSM)
Join IDDI and Clario’s experts to learn how combined advanced biostatistics and innovative integrated randomization and trial supply management system…
View WebinarIDDI speaking at National Academies of Sciences, Engineering, and Medicine’s Workshop
Join IDDI at the virtual workshop organized by the National Academies of Sciences, Engineering and Medicine from 30-31 January 2023…
IDDI Newsletter – January 2023
NEWS & EVENTS IDDI APPOINTS LINDA DANIELSON AS ITS NEW CHIEF EXECUTIVE OFFICER IDDI announces the appointment of Linda Danielson…
ADAPTING THE RANDOMIZATION ALGORITHM
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…
ADDING A STRATIFICATION FACTOR DURING THE STUDY
Discover how a Sponsor reached the overall balance amongst 2 arms by adding a stratification factor. Read the case study!…
OPTIMIZING THE DRUG SUPPLY STRATEGY
Predictive Drug Supply Model Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply…
The Added Value of Biostatistics-Driven Randomization and Trial Supply Management System (RTSM)
Join IDDI and Clario’s experts to learn how combined advanced biostatistics and innovative integrated randomization and trial supply management system…
Happy Holiday Season
Happy Holiday Season from the IDDI team Thank you for all your support throughout the year. Wishing you…
Why do so Many Phase III Fail?
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
IDDI at JP Morgan Week 2023
Meet IDDI at the JP Morgan 41st Annual Healthcare Conference Week 2023 and join us for an exciting Networking Drinks!…
IDDI appoints Linda Danielson as its new Chief Executive Officer
Ottignies, BELGIUM, December 6, 2022 – International Drug Development Institute (IDDI), a privately held, expert biostatistical and clinical data services…